EssilorLuxottica Reports Revenue Growth, Expanding Margins for First Half of 2024, Addresses 'Strategic Pillars' With Recent Acquisitions and Upcoming Launches

By Staff
Friday, July 26, 2024 8:05 AM EssilorLuxottica reports revenue growth, expanding margins for first half of 2024; Kering Eyewear revenue rises for first half of 2024; Bausch + Lomb acquires Trukera Medical; Silmo names Alexis Mabille chairman of 2024 Silmo d’Or Awards; and Topcon and Orbis International expand diabetic retinopathy screening in Rwanda all topped this week’s VMAIL news feed. Click on the headlines below to catch up on anything you might have missed.

Kering Eyewear Sees Rise in Revenue for First Half of 2024, While Total Kering Group Revenue Falls

By Staff
Thursday, July 25, 2024 12:27 AM PARIS—Kering Eyewear, part of the global luxury group Kering, has reported revenue of €914 million in the first half of 2024, up 5 percent as reported and up 6 percent on a comparable basis. In the second quarter, Kering Eyewear's sales rose by 3 percent both on a comparable basis and as reported, driven by solid progression of the brands in its portfolio, the Group said. Overall, revenue from the Kering Eyewear and Corporate segment amounted to €1.1 billion for the first half of 2024, mainly attributable to activities of Kering Eyewear and Kering Beauté, the latter including the sales of Creed.

Bausch + Lomb Acquires Diagnostic Company Trukera Medical

By Staff
Wednesday, July 24, 2024 12:24 AM VAUGHAN, Ontario—Global eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) announced yesterday that an affiliate has acquired Trukera Medical from its private equity owner, AccelMed Partners, and other shareholders. Bausch + Lomb indicated that the acquisition will expand its surgical presence in the United States and contribute to its position in the field of dry eye. A U.S.-based privately held ophthalmic medical diagnostic company, Trukera Medical commercializes the ScoutPro Osmolarity System, an automated device intended to quantitatively measure the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in conjunction with other methods of clinical evaluation. Hyperosmolarity, a condition that is not detectable by slit lamp examination, is a leading indicator and central etiology of asymptomatic DED and ocular surface disease (OSD), the company emphasized; this can negatively affect corneal, cataract and refractive surgery outcomes if not treated effectively prior to the procedure.

Silmo Names Alexis Mabille Chairman of 2024 Silmo d’Or Awards

By Staff
Tuesday, July 23, 2024 12:24 AM PARIS—Silmo has named fashion designer Alexis Mabille as chairman of the 2024 Silmo d’Or Awards, according to an announcement from Silmo. From Lyon, France, Mabille graduated in 1997 from the Chambre Syndicale de la Haute Couture Parisienne before working with major Parisian fashion houses, according to Silmo. He established his eponymous brand in 2005, which includes men's and women's ready-to-wear, accessory and tailored collections; Mabille is most famous for his iconic bow tie designs, and has been on the official calendar of Haute Couture since 2021, the announcement said.

Topcon and Orbis International Collaborate to Expand Diabetic Retinopathy Screening in Rwanda

By Staff
Monday, July 22, 2024 12:24 AM OAKLAND, N.J.—Topcon Healthcare, a provider of medical devices and software solutions for the global eyecare community, announced that it has joined forces with Orbis International, a global nonprofit organization delivering sight-saving programs in more than 200 countries and territories, and the Rwanda International Institute of Ophthalmology (RIIO), to expand diabetic retinopathy screening in Rwanda. The company also shared that it has donated NW400 and NW500 robotic retinal cameras for use in diabetic retinopathy screenings for patients with diabetes in Kigali, the capital of Rwanda.

Optometry Giving Sight Launches New Year-Round Giving Campaign for Optometry Practices

By Staff
Friday, July 19, 2024 8:05 AM Optometry Giving Sight launches new year-round giving campaign; EssilorLuxottica to acquire Supreme from VF Corporation; VSP Vision names Charlie Biegel president of Eyefinity; McGee Group names Gina Kwok marketing director; and Prevent Blindness holds Focus on Eye Health Summit all topped this week’s VMAIL news feed. Click on the headlines below to catch up on anything you might have missed.

EssilorLuxottica to Acquire Supreme From VF Corporation

By Staff
Thursday, July 18, 2024 12:27 AM PARIS and DENVER—EssilorLuxottica, a global leader in the optical industry, and VF Corporation, a global leader in branded lifestyle apparel, footwear and accessories, announced that they entered into a definitive agreement for EssilorLuxottica to acquire the Supreme brand from VF for $1.5 billion in cash. A New York-city based skate culture brand, Supreme was established in 1994 and has expanded into a global community, with 17 retail stores in the U.S., Asia and Europe, and an e-commerce platform across all regions. It runs a digital-first business.

VSP Vision Names Charlie Biegel President of Eyefinity

By Staff
Wednesday, July 17, 2024 12:24 AM RANCHO CORDOVA, Calif.—VSP Vision announced today that it has promoted Charlie Biegel to president of Eyefinity, a VSP Vision company that provides cloud-based practice management and electronic health records solutions to the eyecare industry. He will report to Scott Hopeck, VSP Vision’s chief commercial officer. Since 2014, Biegel has served as chief operating officer of Eyefinity and previously served as chief technology officer. “For over a decade, Charlie’s leadership, technology expertise and customer-centric mindset have helped elevate Eyefinity’s suite of solutions to meet the changing needs of eyecare practices,” said Hopeck.

McGee Group Names Gina Kwok Marketing Director

By Staff
Tuesday, July 16, 2024 12:24 AM MARIETTA, Ga.—McGee Group, a leader in the design and manufacturing of branded eyewear, has announced the appointment of Gina Kwok as marketing director. Kwok joins McGee after a distinguished career at the Savannah College of Art and Design (SCAD) in Atlanta, where she served as associate chair of luxury and brand management and associate chair and professor of fashion marketing and management. Before joining SCAD, Kwok served as vice president of marketing at Boxcraft and vice president of apparel marketing at AmericasMart.

Prevent Blindness Holds 13th Annual Focus on Eye Health Summit

By Staff
Monday, July 15, 2024 12:24 AM CHICAGO—Prevent Blindness, a nonprofit eye health and safety organization, hosted its 13th annual Prevent Blindness Focus on Eye Health Summit on July 10 and 11, 2024. This year’s Summit included a variety of presentations related to the theme “Being Seen and Heard.” More than 800 registrants of the free, virtual and interactive two-day event were able to access an exhibitor hall, participate in “coffee chats” with fellow attendees and attend presentations on a variety of vision and public health topics led by leaders from across the country.

NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million

By Staff
Friday, July 12, 2024 8:05 AM NovaBay Pharmaceuticals reports preliminary Q2 2024 net revenue; AAO and NANOS offer advice on weight loss drug and eye health risk; ECPs’ gross revenue decreased, Jobson Tracker says; Bausch + Lomb releases “State of Dry Eye” survey; and ECPs expect changes to workload, bottom line in response to Eyeglass Rule's final updates all topped this week’s VMAIL news feed. Click on the headlines below to catch up on anything you might have missed.

American Academy of Ophthalmology and North American Neuro-Ophthalmology Society Offer Advice on Weight Loss Drug and Eye Health Risk

By Staff
Thursday, July 11, 2024 12:24 AM SAN FRANCISCO—The American Academy of Ophthalmology and the North American Neuro-Ophthalmology Society have issued a response to a recent study that suggests patients taking semaglutide—the active ingredient in Ozempic and Wegovy—may be at higher risk of developing non-arteritic anterior ischemic optic neuropathy, or NAION, an eye condition that can cause blindness. The study, conducted by researchers at Harvard University, was published on July 3, 2024 in JAMA Ophthalmology. “Because diabetes is a known risk factor for NAION, patients with diabetes who qualify for GLP-1 treatment may be at higher risk for NAION to begin with," Andrew Lee, MD, clinical spokesperson for the American Academy of Ophthalmology and a neuro-ophthalmologist at Houston Methodist Hospital, told VM.

The National Average for Gross Revenue at ECP Locations Decreased for the Week of July 1–7, Jobson’s Latest Practice Performance Tracker Shows

By Staff
Wednesday, July 10, 2024 12:24 AM NEW YORK—The national average for gross revenue at ECP locations decreased last week, July 1–7, when compared with the previous week, at a rate of -36 index points due to last week’s July Fourth Independence Day holiday. That places gross revenue at a level -26 index points below where it was at this point in time (Week 27) when compared with last year (2023), -18 points below the same period in 2022, -12 points below 2021, -1 point below 2020 and 17 points above 2019, according to Jobson’s most recent Practice Performance Tracker.

Bausch + Lomb Releases ‘State of Dry Eye’ Survey, Aims to Increase Awareness and Education

By Staff
Tuesday, July 9, 2024 12:24 AM VAUGHAN, Ontario—During July's Dry Eye Awareness campaign, Bausch + Lomb Corporation (NYSE/TSX: BLCO), a global eye health company, has shared results from the company’s inaugural State of Dry Eye survey, which explores American adults' experiences of living with dry eye. Dry eye is increasingly common and can range from occasional symptoms of dryness to a chronic condition called dry eye disease, according to the survey. The survey revealed that the majority of respondents may not know that their symptoms—which can include redness, fluctuating vision, a scratchy, gritty, tired or heavy feeling, or overall eye irritation—may be associated with eye dryness.

ECPs Expect Changes to Workload, Bottom Line in Response to Eyeglass Rule's Final Updates, Jobson Research Survey Finds

By Staff
Monday, July 8, 2024 12:24 AM NEW YORK—A Jobson Research poll of opticians, optometrists and ophthalmologists in response to recent updates by the Federal Trade Commission (FTC) to the Eyeglass Rule shows that the changes will have moderate to significant impact on practices' workload and bottom line. As recently reported in VMAIL, the FTC announced final updates late last month to its Ophthalmic Practice Rules, also known as the Eyeglass Rule, in what the organization stated was an effort to increase compliance with the requirement that ophthalmologists and optometrists provide patients with a free copy of their prescription immediately following a refractive eye exam. Among the updates are the requirements that ECPs must now ask patients to sign a statement confirming they received their prescription, keep a record of that confirmation for at least three years, and offer patients the option of a digital prescription.